abstract |
The invention relates to polypeptides having at least two antigen-binding domains, where at least one of the antigen binding domains is a T cell receptor single-variable domain (svd-TCR). The disclosure provides T cell receptors, polynucleotides, vectors, and immune cells comprising same, and methods of using same to treat diseases or disorders in a subject. |